EDGAR Filing Documents for 0001104659-17-015192

Form 8-K - Current report:

SEC Accession No. 0001104659-17-015192

Filing Date

2017-03-08

Accepted

2017-03-08 16:11:08

Documents

Period of Report

2017-03-02

Items

Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a17-7857_18k.htm	8-K	24550
2	EX-99.1	a17-7857_1ex99d1.htm	EX-99.1	108345
3	GRAPHIC	g78571mmi001.jpg	GRAPHIC	3344
	Complete submission text file	0001104659-17-015192.txt		138914

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421

Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200

T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)